Technology
Alcorlab has developed the EasyGene24 apparatus that can synthesize oligonucleotides, LNA's and peptides. The patented technology is flexible in design allowing for easy up-scaling of chemicals and columns. In addition to the oligonucleotide synthesis, the technology has the ability to synthesize LNA and proteins in one single machine with a service-friendly functionality.
Alcorlab founder Peter Jepsen has more than 20 years of experience in the design and production of laboratory equipment of which the last 12 years has been focused exclusively on design and manufacturing of oligonucleotide synthesis equipment.
Value Proposition
The EasyGene24 halves the price of synthesizing compared to current products on the market, while being more flexible and easier to upscale. This will provide the opportunity for mid-sized and smaller laboratories to work on drug development and molecular biology projects, which was previously not economically feasible.
Additional Information